Supriya Lifescience Limited (NSE: SUPRIYA)
595.05
+11.30 (1.94%)
Sep 6, 2024, 3:30 PM IST
Supriya Lifescience Company Description
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.
It offers anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, and anti-malarial products, as well as vitamins and xanthine derivatives.
The company was founded in 1987 and is headquartered in Mumbai, India.
Supriya Lifescience Limited
Country | India |
Founded | 1987 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 392 |
Contact Details
Address: 207/208 Udyog Bhavan Mumbai, 400063 India | |
Phone | 91 22 4033 2727 |
Website | supriyalifescience.com |
Stock Details
Ticker Symbol | SUPRIYA |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE07RO01027 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Satish Waman Wagh | Founder and Executive Chairman |
Krishna Raghunathan | Chief Financial Officer |
Dr. Shireesh Bhalchandra Ambhaikar | Technical Head |
Shweta Shivdhari Singh | Compliance Officer and Company Secretary |
Smita Satish Wagh | Whole-time Director |
Saloni Satish Wagh | Managing Director |
Dr. Sushanta Kumar Gouranga Mishra | Chief Scientific Officer |
Shivani Satish Wagh | Joint Managing Director |
Dr. Prashant Baban Zate | Head of Corporate Quality Assurance and Regulatory Affairs |